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Introduction
Cardiac resynchronization therapy (CRT) has
recently become an established therapy for patients
with NYHA class III/IV systolic heart failure and
prolonged QRS duration [1]. In addition to improve-
ment in exercise capacity, NYHA symptoms class,
and quality of life, evidence of the arrest or revers-
al of ventricular remodeling has been demonstrat-
ed [2]. A recent meta-analysis found that CRT re-
duces mortality from progressive heart failure and
suggested a trend toward longer survival in patients
treated with CRT [3]. Total mortality was also re-
duced in two recent trials, one of which included
CRT in combination with defibrillation therapy,
while the other did not [4, 5].
Although a delayed or halted progression of
cardiac dysfunction may be sufficient to prevent
malignant ventricular tachyarrhythmias, there is
still lingering uncertainty regarding the presence
and magnitude of antiarrhythmic effects of CRT per
se. Furthermore, there is experimental as well as
anecdotal clinical evidence that left ventricular pac-
ing may have proarrhythmic potential. The present
review examines the available experimental and
clinical evidence of potential proarrhythmic effects
of CRT and the proposed electrophysiological
mechanisms. Similarly, the evidence for an-
tiarrhythmic effects of CRT will be reviewed.
A potential proarrhythmic effect of CRT in a sub-
group of patients is an issue of considerable impor-
tance in view of the current controversy regarding
the need of ICD backup in a majority of, if not in all
patients receiving CRT. The arguments for [6] and
against [7] this position seem to reflect, in part, dif-
fering points of views on each side of the Atlantic
ocean.
Evidence for a proarrhythmic effect
of left ventricular pacing
Experimental evidence
Medina-Ravell et al were the first to point out
that the common design for CRT, i.e. simultaneous
pacing of the right ventricular endocardium and left
ventricular epicardium, is associated with a non-
physiological ventricular activation sequence [8].
This may augment transmural heterogeneity of re-
polarization intrinsic to ventricular myocardium
and, as a consequence, prolong the QT and JT in-
tervals on the ECG. The cellular mechanisms un-
derlying the pacing site-dependent alterations in
ventricular repolarization were studied in an exper-
imental model consisting of an arterially perfused
rabbit left ventricular (LV) wedge preparation in
which transmembrane action potentials from endo-
cardium and epicardium could be simultaneously
recorded together with a transmural ECG. In the
experimental preparation, transmural dispersion of
repolarization (TDR) was defined as the difference
between the longest and shortest repolarization
times across the LV wall. The authors showed that
switching from endocardial to epicardial pacing re-
sulted in a change of activation sequence between
epicardium and endocardium, which was associat-
ed with an increase in QT interval and TDR with-
out a parallel increase in endocardial and epicardial
transmembrane action potential duration (APD).
A more recent study examined the cellular
basis for QT prolongation after reversal of the di-
rection of activation of the LV wall [9]. Based on
previous investigations documenting the contribu-
tion of M cells to TDR, this study postulated that
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delayed activation and repolarization of M cells,
coupled with earlier activation and repolarization of
epicardial cells, may result in QT prolongation, de-
velopment of transmural heterogeneity, and torsade
de pointes after a shift from endocardial to epicar-
dial activation of the LV wall in the absence and
presence of rapidly activating delayed rectifier po-
tassium current (IKr) blockade. This hypothesis was
tested in a 1-dimensional mathematical model of
transmural conduction as well as in the coronary-
perfused canine LV wedge preparation. The results
of the mathematical simulation and the experimen-
tal data confirmed that intrinsic heterogeneity ex-
ists within the ventricular myocardium and that this
electrical heterogeneity is amplified when the nor-
mal direction of activation of the ventricular wall is
reversed. Epicardial activation augments TDR be-
cause the epicardial action potential activates and
repolarizes earlier and the M cells with the longest
APD located in the deep subendocardium activate
and repolarize later compared with endocardial acti-
vation of the ventricular wall. The additional conduc-
tion delay encountered between epicardial and
M regions during epicardial stimulation contributes to
the amplification of TDR. The delayed activation and
repolarization of the M cells, when coupled with ear-
lier activation of repolarization of epicardial cells, cre-
ates the substrate for the development of reentry.
In another experimental study, the role of volt-
age output, interventricular delay, and pacing sites
in the development of ventricular arrhythmias were
investigated during biventricular pacing or LV pac-
ing [10]. Voltage-sensitive dye was used in  ischem-
ic Langerdorff-perfused guinea pig hearts to meas-
ure ventricular activation times and examine con-
duction patterns during multisite pacing from three
right ventricular (RV) and four LV sites. Isochron-
al maps of RV and LV activation were plotted.
Ischemia was produced by gradually halving the
perfusion output. Pacing the RV apex and the base
of the LV anterior wall was associated with the most
homogeneous and rapid activation pattern  and no
inducible arrhythmia. On the other hand, simulta-
neous RV and LV pacing at high voltage output in-
duced ventricular fibrillation with complex three-
dimensional propagation patterns, independent of
the pacing sites.
Clinical evidence
In an early report by Medina-Ravell et al. [8],
the QT interval, JT interval, and TDR were meas-
ured in 29 patients with heart failure during RV
endocardial pacing, biventricular pacing, and LV
epicardial pacing. LV epicardial pacing and biven-
tricular pacing led to significant QT and JT prolon-
gation. LV epicardial pacing also enhanced TDR,
defined as the interval between the peak and the
end of the T wave (Tpeak-end). Frequent R-on-T extra-
systoles generated by biventricular and LV pacing
but completely inhibited by RV pacing occurred in
4 patients, of whom one patient developed multi-
ple episodes of nonsustained polymorphic ventricu-
lar tachyarrhythmia (VT) and another suffered in-
cessant Torsade de Pointes (TdP) VT. These data
suggested that, in a subpopulation of patients with
prolonged QT interval, secondary to heart failure,
electrolyte abnormalities, or exposure to agents
with class III antiarrhythmic actions, a biventricu-
lar or LV epicardial pacing induced increase in QT
interval and TDR may be a potential risk for the de-
velopment of TdP.  Several case reports subse-
quently followed that showed the de novo develop-
ment and/or increase of VT after CRT [11, 12].
A recent case report from our laboratory is typical
of these reports [13]. The development of polymor-
phic VT following CRT seems to occur in the early
post-operative period. There is no data to suggest
that this early proarrhythmic effect persists or can
be mitigated during long term follow up. Experi-
mental studies suggest that change in transmural
activation can result in remodeling of cardiac repo-
larization [14, 15]. Whether prolonged CRT results
in electrical remodeling that improves the under-
lying ventricular dispersion of repolarization in
a particular patient requires further investigation.
Evidence for an antiarrhythmic effect
of cardiac resynchronization therapy
Experimental evidence
There are very few experimental studies that
examined  direct antiarrhythmic effects of CRT.
Restivo et al. [16] published one of the early exper-
imental studies that demonstrated a direct an-
tiarrhythmic effect of carefully applied dual site
ventricular stimulation in the canine post-infarction
model. In this model, a one stage ligation of the left
anterior descending artery results in an anterosep-
tal infarction with a surviving electrophysiological-
ly abnormal epicardial layer. A figure of eight reen-
trant ventricular tachycardia could be induced by
programmed premature stimulation. Refractoriness
in the surviving epicardial layer is distributed as
eccentrically layered contours that increase monot-
onically toward the core of the infarction. A prema-
ture stimulus would result in an arc of functional
conduction block at sites of dispersion of repolari-
zation, usually at the border of the ischemic zone.
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Subsequent reentrant activation is dependent on
both the extent of the arc of functional block and
the degree of conduction delay of the circulating
wave front before refractoriness expires at sites
proximal to arc allowing re-excitation to take place.
The spatial distribution of refractoriness on the
heart could be modified by a dual site ventricular
stimulation during the basic rhythm. In the study,
one pacing site was the RV outflow tract while the
second site was the ischemic LV zone. Properly
sequenced stimulation at the two sites could mod-
ify the spatial distribution of refractoriness in a way
that prevented the induction of reentry.  Preven-
tion of reentry was the result of several factors, but
primarily due to reduction and/or modification of the
extent of the arc of functional conduction block.
Biventricular pacing with asynchronous premature
stimulation at the ischemic site with prolonged re-
fractoriness in comparison to the RV site could
“peel back” refractoriness in the ischemic zone and
abolish entirely the arc of block.
Clinical evidence
In the last few years several clinical reports
have strongly suggested that cardiac structural and
contractile reverse remodeling following CRT could
also result in a favorable antiarrhythmic effect.
These clinical reports could be grouped in two main
categories: A) favorable changes in the overall in-
cidence of spontaneous VT, and B) amelioration of
the arrhythmogenic substrates associated with re-
duced systolic function and heart failure.
A. Favorable changes in the overall inci-
dence of VT. A comprehensive analysis of the com-
bined InSync-ICD and Contact-CD population found
that CRT was associated with no measurable in-
crease in the incidence of polymorphic VT or re-
duction in monomorphic VT [17]. However, other
reports showed evidence that the incidence of ma-
lignant VT is reduced following CRT. These reports
relied on the decrease in appropriate ICD therapy in
patients with CRT as evidence of an antiarrhythmic
effect [18, 19]. There is also anecdotal evidence that
electrical storm may be suppressed by ICD [20, 21].
On the other hand, a surrogate marker of the an-
tiarrhythmic effect of CRT could be invoked from
studies that analyzed the changes in the inducibili-
ty of VT following CRT [22–24]. In one study, the
induction of VT was reduced in patients with sig-
nificant LV reverse remodeling after 6 months of
implanting a CRT device [24]. There was a strik-
ing difference between patients with loss of induc-
ibility and patient who remained inducible. Patient
with loss of inducibility had a significant reduction
in LV end-diastolic and end-systolic volumes com-
pared to patients who remained inducible. The an-
tiarrhythmic effect was attributed to reduced LV wall
stress and its consequent effect on LV structure.
B. Amelioration of the arrhythmogenic
substrates. The arrhythmogenic substrates in pa-
tients with depressed LV systolic function and heart
failure include dispersion of repolarization, altered
neurohumoral signaling, alteration in calcium home-
ostasis, altered conduction, myocardial ischemia,
and genetic predisposition [25]. There is clinical
evidence that, at least, the first two substrates are
ameliorated following successful CRT with evi-
dence of reversible remodeling.
1) Improvement  of dispersion of repolarization:
Using high-resolution surface electrocardiogram
(ECG), Berger et al showed that biventricular pac-
ing was associated with a significant reduction of
ECG markers of ventricular dispersion of repo-
larization including interlead QT dispersion, RMS
Tpeak-end interval, Tpeak-amplitude, and the area (inte-
gral) of the Tpeak-end curve [26]. In another ECG sim-
ulation study, repolarization indices associated with
CRT were found to be related to pacing-induced
activation sequence rather than TDR [27]. TDR
during biventricular and LV epicardial pacing was
not larger than TDR during conventional RV endo-
cardial pacing.
A positive microvolt T-wave alternans (TWA)
is considered an indirect marker of increased dis-
persion of repolarization as well as a strong inde-
pendent predictor of malignant VT and sudden car-
diac death [28]. In a preliminary study by Turitto
et al. [29], the prevalence of TWA during different
pacing modalities was investigated in a group of
patients who received CRT. TWA was recorded,
during atrial pacing (AAI) at a rate of 110/min,
as well as during DDD-RV pacing and DDD-biven-
tricular pacing at the same rate and with short atrio-
ventricular delay, in order to obtain ventricular cap-
ture. Criteria for positive TWA were: alternans
> 1 min with Valt (square root of alternans power)
> 1.9 uv and alternans ratio (ratio of alternans to
standard deviation of background noise) > 3 in ≥ 1
orthogonal lead or ≥ 2 precordial leads. In this
study, AAI and RV pacing resulted into a high prev-
alence of tachycardia-induced TWA, while BiV pac-
ing was associated with amelioration of all TWA
indices.
2) Amelioration of abnormal neurohumoral sig-
naling: There is plethora of clinical reports show-
ing that CRT induces favorable neurohumoral
changes. This has been shown utilizing direct
recordings of sympathetic nerve activity [30], or
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indirect indices of sympathetic activity like 132I-MBIG
uptake, which is used as an index of neural nore-
pinephrine reuptake and retention [31]. There is
also data showing decrease in brain natriuretic pep-
tide (BNP) levels which is used as an index of LV
end-diastolic pressure [31]. Favorable changes in
heart rate profile and heart rate variability (HRV)
have also been shown following CRT and are used
as surrogate markers of the sympathetic-parasympa-
thetic interaction to the heart [32–34]. In one study,
patients with sub-optimal LV lead position associ-
ated with no significant functional and structural
improvement had no change, or even worsening, of
HRV [34]. Lack of HRV improvement four weeks af-
ter CRT identified patients at high risk for major car-
diovascular events [34]. Another surrogate marker of
the autonomic nervous system is baroreceptor sen-
sitivity. A recent case report showed that CRT could
significantly improve this particular index [35].
Conclusions
Available evidence supports the hypothesis
that CRT results into favorable structural as well
as electrical remodeling. The latter seems to be
related, to a large extent, to the amelioration of the
arrhythmogenic substrates associated with de-
pressed LV systolic function and heart failure. How-
ever, a direct electrophysiological effect due to fa-
vorable remodeling of repolarization with reduction
of the dispersion of repolarization can not be ruled
out. On the other hand, in a small subgroup of pa-
tient, CRT could increase the dispersion of repo-
larization and induce malignant VT. There is a cur-
rent debate of whether an ICD backup is indicated
in a majority of, if not all, patient with CRT. Because
some patients may receive a CRT-pacemaker rather
than a CRT-defibrillator, it is imperative that crite-
ria for the selection of this group of patients with
presumably low risk for sudden arrhythmic death
as well as the proarrhythmic effect of CRT be clear-
ly defined.
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